Cargando…
CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression
Huntington's disease (HD) is a fatal, neurodegenerative disorder in which patients suffer from mobility, psychological and cognitive impairments. Existing therapeutics are only symptomatic and do not significantly alter the disease progression or increase life expectancy. HD is caused by expans...
Autores principales: | Zaghloul, Eman M., Gissberg, Olof, Moreno, Pedro M.D., Siggens, Lee, Hällbrink, Mattias, Jørgensen, Anna S., Ekwall, Karl, Zain, Rula, Wengel, Jesper, Lundin, Karin E., Smith, C.I. Edvard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435994/ https://www.ncbi.nlm.nih.gov/pubmed/28334749 http://dx.doi.org/10.1093/nar/gkx111 |
Ejemplares similares
-
Oligonucleotides Targeting DNA Repeats Downregulate
Huntingtin Gene Expression in Huntington's
Patient-Derived Neural Model System
por: Umek, Tea, et al.
Publicado: (2021) -
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
por: Østergaard, Michael E., et al.
Publicado: (2013) -
Chemical Modifications and Design Influence the Potency of Huntingtin Anti-Gene Oligonucleotides
por: Saher, Osama, et al.
Publicado: (2023) -
Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway
por: Hu, Jiaxin, et al.
Publicado: (2012) -
Highly efficient silencing of microRNA by heteroduplex oligonucleotides
por: Yoshioka, Kotaro, et al.
Publicado: (2019)